NASDAQ: ETHZEthzilla Corp Stock
$10.51-1.28 (-10.86%)
Updated Dec 5, 2025
ETHZ Price
$10.51
Fair Value Price
N/A
Market Cap
$224.90M
52 Week Low
$6.58
52 Week High
$174.54
P/E
-0.07x
P/B
0.51x
P/S
72.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.11M
Earnings
-$225.11M
Gross Margin
100%
Operating Margin
-5,476%
Profit Margin
-5,671.9%
Debt to Equity
1.27
Operating Cash Flow
-$19M
Beta
1.5
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ETHZ Overview
ETHZilla operates in digital asset management, gaming, and entertainment. The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts. Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ETHZ's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ETHZ news, forecast changes, insider trades & much more!
ETHZ News
Overview
Due Diligence Score
–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ETHZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ETHZ is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ETHZ is good value based on its book value relative to its share price (0.51x), compared to the US Biotechnology industry average (5.29x)
P/B vs Industry Valuation
ETHZ is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ETHZ due diligence checks available for Premium users.
Valuation
ETHZ fair value
Fair Value of ETHZ stock based on Discounted Cash Flow (DCF)
Price
$10.51
Fair Value
$48.40
Undervalued by
78.29%
ETHZ is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ETHZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.07x
Industry
186.51x
Market
46.7x
ETHZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.51x
Industry
5.29x
ETHZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ETHZ's financial health
Profit margin
Revenue
$4.1M
Net Income
-$216.7M
Profit Margin
-5,273.3%
ETHZ's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ETHZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.0B
Liabilities
$564.2M
Debt to equity
1.27
ETHZ's short-term assets ($561.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ETHZ's short-term assets ($561.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ETHZ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ETHZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$16.4M
Investing
$0.0
Financing
$825.5M
ETHZ's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ETHZ vs Biotech Stocks
Ethzilla Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.